SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041634
Filing Date
2021-08-05
Accepted
2021-08-05 16:31:41
Documents
84
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pbyi-10q_20210630.htm   iXBRL 10-Q 2978150
2 EX-31.1 pbyi-ex311_6.htm EX-31.1 9302
3 EX-31.2 pbyi-ex312_12.htm EX-31.2 9303
4 EX-32.1 pbyi-ex321_11.htm EX-32.1 6264
5 EX-32.2 pbyi-ex322_9.htm EX-32.2 6280
  Complete submission text file 0001564590-21-041634.txt   11702570

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20210630.xsd EX-101.SCH 66866
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20210630_cal.xml EX-101.CAL 77285
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20210630_def.xml EX-101.DEF 208494
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20210630_lab.xml EX-101.LAB 546513
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20210630_pre.xml EX-101.PRE 420558
11 EXTRACTED XBRL INSTANCE DOCUMENT pbyi-10q_20210630_htm.xml XML 2561163
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 211148831
SIC: 2834 Pharmaceutical Preparations